Correlative study of the morphology and C19-steroid metabolism of benign and cancerous human prostatic tissue
- 31 March 1977
- Vol. 39 (4) , 1517-1534
- https://doi.org/10.1002/1097-0142(197704)39:4<1517::aid-cncr2820390425>3.0.co;2-#
Abstract
Perineal punch biopsy specimens of human prostate with benign hyperplasia (BPH), well- and poorly differentiated adenocarcinoma and transitional cell carcinoma were incubated with testosterone-1,2-3H and 5.alpha.-dihydrotestosterone-1,2-3H. Incubations were done using a single tissue-radiosubstrate ratio and time point. Resulting radiosteroid patterns were related to histologic and ultrastructural features of these tissues. Well differentiated neoplasms had ultrastructural characteristics closely resembling hyperplasic epithelia. In BPH and well differentiated carcinomas the C19-steroids were metabolized by the 17.beta.-hydroxysteroid pathway. Cells in poorly differentiated adenocarcinoma and transitional cell carcinoma lacked the cytoplasmic organelles responsible for secretion. Formation of 5.alpha.-reduced 17.beta. hydroxysteroids was decreased in these carcinomas, while conversion to 17-oxosteroid radiometabolites remained unchanged or was increased. These results indicate that loss of prostatic differentiation is attended by a trend from reductive toward oxidative radiotestosterone metabolism. Even in NADPH supplemented preparations of the majority of poorly differentiated tumors there was diminished transformation to 5.alpha.-dihydrotestosterone, the key intracellular hormone in the expression of androgenic activity in the prostate. These findings may explain why poorly differentiated prostatic neoplasms are frequently unresponsive to antiandrogenic therapy.This publication has 25 references indexed in Scilit:
- EFFECT OF OESTRADIOL-17β AND PROGESTERONE ON THE METABOLISM OF TESTOSTERONE BY HUMAN PROSTATIC TISSUEJournal of Endocrinology, 1974
- Fine Structure and Cytochemistry of Human Prostatic CarcinomaPublished by Elsevier ,1974
- Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical StagingJournal of Urology, 1974
- Neuere Ergebnisse über den Stoffwechsel von3H-Testosteron und3H-5α-Dihydrotestosteron in Prostata und ProstataadenomenUrologia Internationalis, 1973
- Quantification of free dihydrotestosterone in blood plasma and tissueAnalytical Biochemistry, 1972
- A Comparative Study of the Conversion of Testosterone to 17β-Hydroxy-5α-androstan-3-one (Dihydrotestosterone) by Prostate and EpididymisJournal of Clinical Endocrinology & Metabolism, 1969
- Selective Retention of Dihydrotestosterone by Prostatic NucleiNature, 1968
- The Conversion of Testosterone to 5α-Androstan-17β-ol-3-one by Rat Prostate in Vivo and in VitroJournal of Biological Chemistry, 1968
- Carcinoma of the prostate.Enzyme histochemistryCancer, 1967
- Estrogen-treated prostatic cancer.The variation in responsiveness of tumor cellsCancer, 1960